A
AposTherapy
Medical technology company providing treatment for various orthopedic conditions
About AposTherapy
AposTherapy is a healthcare startup that specializes in providing innovative treatment for chronic knee pain, particularly knee osteoarthritis. The company operates in the medical and wellness market, targeting individuals who suffer from knee pain due to osteoarthritis. This condition is common among older adults but can affect people of all ages.
AposTherapy offers a unique treatment method that combines elements of physiotherapy, orthotics (custom-made shoe inserts), and bracing into a single, wearable device. This device is essentially a pair of clinical shoes designed to realign the patient's biomechanics (how the body moves) and strengthen the muscles around the knee. The treatment aims to reduce pain and prevent further damage by improving the way patients walk and move.
The business model of AposTherapy is centered around direct-to-consumer sales and clinical services. Clients can book appointments through the company's website to receive a personalized treatment plan. The company makes money by selling these clinical shoes and providing ongoing support and adjustments to ensure the treatment remains effective over time.
AposTherapy's target clients are individuals experiencing chronic knee pain, particularly those diagnosed with knee osteoarthritis. The company also collaborates with healthcare providers and insurance companies to make its treatment more accessible to a broader audience.
In summary, AposTherapy is a healthcare startup offering a clinically proven, non-invasive treatment for knee osteoarthritis through a combination of physiotherapy, orthotics, and bracing in a wearable device. The company serves individuals with chronic knee pain, operates in the medical and wellness market, and generates revenue through direct sales and clinical services.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2004
- Headquarters
- Tel Aviv-Yafo, Israel
- Employees
- 92
- Open positions
- None listed
- Dealroom signal
- 61.9/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Mobility, Rehabilitation, Risk Management, Patient Care, Chronic Disease, Orthopedic, Non-Surgical, Tech for Patients, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Feb 2020 | $11M | $44M | aMoon Fund | ↗ |
| DEBT✓Debt | Aug 2016 | $2.5M | — | Viola Credit | — |
Growth signals
Latest recorded traffic for AposTherapy is 550 monthly website visits, up 31% over the last three months. AposTherapy's team declined 21.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Aviv Venture Capital
Pitango Venture Capital
Invus
Series B and later2 investors entered at this stage
Viola Credit
aMoon Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about AposTherapy on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AposTherapy’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







